BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 30901662)

  • 1. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
    Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norcycloartocarpin targets Akt and suppresses Akt-dependent survival and epithelial-mesenchymal transition in lung cancer cells.
    Nonpanya N; Sanookpan K; Joyjamras K; Wichadakul D; Sritularak B; Chaotham C; Chanvorachote P
    PLoS One; 2021; 16(8):e0254929. PubMed ID: 34383763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth.
    Yang X; Zhao D; Li Y; Li Y; Cui W; Li Y; Li H; Li X; Wang D
    Thorac Cancer; 2020 Oct; 11(10):2858-2866. PubMed ID: 32875729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy.
    Huo H; Feng Y; Tang Q
    Cancer Chemother Pharmacol; 2024 May; 93(5):397-410. PubMed ID: 38172304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics.
    Qin Y; Chen K; Gu W; Dong X; Lei R; Chang Y; Bai X; Xia S; Zeng L; Zhang J; Ma S; Li J; Li S; Xing G
    J Nanobiotechnology; 2018 Jun; 16(1):54. PubMed ID: 29935539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrins as the pivotal regulators of cisplatin response in tumor cells.
    Nasimi Shad A; Moghbeli M
    Cell Commun Signal; 2024 May; 22(1):265. PubMed ID: 38741195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naringenin inhibits migration, invasion, induces apoptosis in human lung cancer cells and arrests tumour progression in vitro.
    Shi X; Luo X; Chen T; Guo W; Liang C; Tang S; Mo J
    J Cell Mol Med; 2021 Mar; 25(5):2563-2571. PubMed ID: 33523599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shrimp Lipids Inhibit Migration, Epithelial-Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression.
    Thepthanee C; Ei ZZ; Benjakul S; Zou H; Petsri K; Innets B; Chanvorachote P
    Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Bacteriorhodopsin May Induce Lung Cancer Cell Cycle Arrest and Suppress Their Proliferation and Migration.
    Wong CW; Ko LN; Huang HJ; Yang CS; Hsu SH
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressive roles of eugenol in human lung cancer cells.
    Fangjun L; Zhijia Y
    Thorac Cancer; 2018 Jan; 9(1):25-29. PubMed ID: 29024500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plantamajoside modulates the proliferation, stemness, and apoptosis of lung carcinoma via restraining p38MAPK and AKT phosphorylation.
    Li Y; Han R; Cao W
    Transl Cancer Res; 2020 Jun; 9(6):3828-3841. PubMed ID: 35117750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non-small cell lung cancer.
    Tang H; Abston E; Sojoodi M; Wang Y; Erstad DJ; Lin Z; Fuchs BC; Tanabe KK; Lanuti M
    JTCVS Open; 2024 Apr; 18():306-321. PubMed ID: 38690408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement and models accounting for cell death capture hidden variation in compound response.
    Bae SY; Guan N; Yan R; Warner K; Taylor SD; Meyer AS
    Cell Death Dis; 2020 Apr; 11(4):255. PubMed ID: 32312951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 knockdown increases the therapeutic sensitivity of lung cancer to cisplatin-induced apoptosis by repressing Parkin-related mitophagy and activating the ROCK1 pathway.
    Liu Y; Fu Y; Hu X; Chen S; Miao J; Wang Y; Zhou Y; Zhang Y
    J Cell Physiol; 2020 Feb; 235(2):1197-1208. PubMed ID: 31270811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jorunnamycin A from
    Ecoy GAU; Chamni S; Suwanborirux K; Chanvorachote P; Chaotham C
    J Nat Prod; 2019 Jul; 82(7):1861-1873. PubMed ID: 31260310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility Technique of Low-passage
    Vinayanuwattikun C; Prakhongcheep O; Tungsukruthai S; Petsri K; Thirasastr P; Leelayuwatanakul N; Chanvorachote P
    Anticancer Res; 2019 Dec; 39(12):6981-6988. PubMed ID: 31810970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action.
    Petsri K; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31117253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumichrome Inhibits Human Lung Cancer Cell Growth and Induces Apoptosis via a p53-Dependent Mechanism.
    Chantarawong W; Kuncharoen N; Tanasupawat S; Chanvorachote P
    Nutr Cancer; 2019; 71(8):1390-1402. PubMed ID: 31074646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells.
    Nonpanya N; Prakhongcheep O; Petsri K; Jitjaicham C; Tungsukruthai S; Sritularak B; Chanvorachote P
    Anticancer Res; 2020 Sep; 40(9):4989-4999. PubMed ID: 32878787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry of Renieramycins. Part 19: Semi-Syntheses of 22-
    Chamni S; Sirimangkalakitti N; Chanvorachote P; Suwanborirux K; Saito N
    Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32785022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.